784
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Experimental study of HIFU incomplete ablation on the damage effect and prognosis of rabbit VX2 breast cancer model

ORCID Icon, , , , , & show all
Article: 2255760 | Received 14 Oct 2022, Accepted 31 Aug 2023, Published online: 19 Sep 2023

References

  • Azamjah N, Soltan-Zadeh Y, Zayeri F. Global trend of breast cancer mortality rate: a 25-Year study. Asian Pac J Cancer Prev. 2019;20(7):2015–2020. doi: 10.31557/APJCP.2019.20.7.2015.
  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209–249.
  • Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. doi: 10.3322/caac.21654.
  • Waks AG, Winer EP. Breast cancer treatment: a review. J Am Med Associat. 2019;321(3):288–300. doi: 10.1001/jama.2018.19323.
  • Yin L, Duan JJ, Bian XW, et al. Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res. 2020;22(1):61. doi: 10.1186/s13058-020-01296-5.
  • Miccoli M. Recent advances in the treatment of breast cancer. Anticancer Agents Med Chem. 2022;22(4):747–747. doi: 10.2174/187152062204220217144704.
  • Lovelace DL, Mcdaniel LR, Golden D. Long-Term effects of breast cancer surgery, treatment, and survivor care. J Midwifery Womens Health. 2019;64(6):713–724. doi: 10.1111/jmwh.13012.
  • Bale R, Putzer D, Schullian P. Local treatment of breast cancer liver metastasis. Cancers (Basel). 2019;11(9):1341. doi: 10.3390/cancers11091341.
  • Maloney E, Hwang JH. Emerging HIFU applications in cancer therapy. Int J Hyperthermia. 2015;31(3):302–309. doi: 10.3109/02656736.2014.969789.
  • Marinova M, Rauch M, Mucke M, et al. High-intensity focused ultrasound (HIFU) for pancreatic carcinoma: evaluation of feasibility, reduction of tumour volume and pain intensity. Eur Radiol. 2016;26(11):4047–4056. doi: 10.1007/s00330-016-4239-0.
  • Peek M, Wu F. High-intensity focused ultrasound in the treatment of breast tumours. Ecancermedicalscience. 2018;12:794. doi: 10.3332/ecancer.2018.794.
  • Marinova M, Wilhelm-Buchstab T, Strunk H. Advanced pancreatic cancer: high-Intensity focused ultrasound (HIFU) and other local ablative therapies. Rofo. 2019;191(3):216–227. doi: 10.1055/a-0820-5564.
  • Ter Haar G. HIFU tissue ablation: concept and devices. Adv Exp Med Biol. 2016;880:3–20.
  • Feril LB, Fernan RL, Tachibana K. High-Intensity focused ultrasound in the treatment of breast cancer. Curr Med Chem. 2021;28(25):5179–5188. doi: 10.2174/0929867327666201111143206.
  • Peek MC, Ahmed M, Napoli A, et al. Systematic review of high-intensity focused ultrasound ablation in the treatment of breast cancer. Br J Surg. 2015;102(8):873–882; discussion 882. doi: 10.1002/bjs.9793.
  • Yin N, Hu L, Xiao ZB, et al. Factors influencing thermal injury to skin and abdominal wall structures in HIFU ablation of uterine fibroids. Int J Hyperthermia. 2018;34(8):1298–1303. doi: 10.1080/02656736.2018.1433880.
  • Zhou Y, Cunitz BW, Dunmire B, et al. Characterization and ex vivo evaluation of an extracorporeal high-intensity focused ultrasound (HIFU) system. J Appl Clin Med Phys. 2021;22(9):345–359. doi: 10.1002/acm2.13074.
  • Elhelf I, Albahar H, Shah U, et al. High intensity focused ultrasound: The fundamentals, clinical applications and research trends. Diagn Interv Imaging. 2018;99(6):349–359.
  • Mauri G, Sconfienza LM, Pescatori LC, et al. Technical success, technique efficacy and complications of minimally-invasive imaging-guided percutaneous ablation procedures of breast cancer: a systematic review and meta-analysis. Eur Radiol. 2017;27(8):3199–3210. doi: 10.1007/s00330-016-4668-9.
  • Palyga I, Palyga R, Mlynarczyk J, et al. The current state and future perspectives of high intensity focused ultrasound (HIFU) ablation for benign thyroid nodules. Gland Surg. 2020;9(2):95–104.
  • Scipione R, Anzidei M, Bazzocchi A, et al. HIFU for bone metastases and other musculoskeletal applications. Semin Intervent Radiol. 2018;35(4):261–267. doi: 10.1055/s-0038-1673363.
  • Xu D, Zou W, Luo Y, et al. Feasibility between bifidobacteria targeting and changes in the acoustic environment of tumor tissue for synergistic HIFU. Sci Rep. 2020;10(1):7772. doi: 10.1038/s41598-020-64661-6.
  • Zhang Y, Yong L, Luo Y, et al. Enhancement of HIFU ablation by sonosensitizer-loading liquid fluorocarbon nanoparticles with pre-targeting in a mouse model. Sci Rep. 2019;9(1):6982. doi: 10.1038/s41598-019-43416-y.
  • Sparchez Z, Mocan T, Radu P, et al. Prognostic factors after percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma. Impact of incomplete ablation on recurrence and overall survival rates. J Gastrointestin Liver Dis. 2018;27(4):399–407. doi: 10.15403/jgld.2014.1121.274.pro.
  • Shi L, Wang J, Ding N, et al. Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy. Nat Commun. 2019;10(1):5421. doi: 10.1038/s41467-019-13204-3.
  • Ning Z, Zhu Z, Wang H, et al. High-intensity focused ultrasound enhances the effect of bufalin by inducing apoptosis in pancreatic cancer cells. Onco Targets Ther. 2019;12:1161–1170. doi: 10.2147/OTT.S185953.
  • Suehiro S, Ohnishi T, Yamashita D, et al. Enhancement of antitumor activity by using 5-ALA-mediated sonodynamic therapy to induce apoptosis in malignant gliomas: significance of high-intensity focused ultrasound on 5-ALA-SDT in a mouse glioma model. J Neurosurg. 2018;129(6):1416–1428. doi: 10.3171/2017.6.JNS162398.
  • Wang Y, Zhai D. High intensity focused ultrasound inhibits breast cancer cell proliferation and promotes cell apoptosis via miR-222-3p/p27Kip1 axis. Int J Clin Exp Med. 2020;13:2205–2215.
  • Zhu XQ, Lu P, Xu ZL, et al. Alterations in immune response profile of Tumor-Draining lymph nodes after High-Intensity focused ultrasound ablation of breast cancer patients. Cells. 2021;10(12):3346. doi: 10.3390/cells10123346.
  • Eranki A, Srinivasan P, Ries M, et al. High-Intensity focused ultrasound (HIFU) triggers immune sensitization of refractory murine neuroblastoma to checkpoint inhibitor therapy. Clin Cancer Res. 2020;26(5):1152–1161. doi: 10.1158/1078-0432.CCR-19-1604.
  • Fucikova J, Kepp O, Kasikova L, et al. Detection of immunogenic cell death and its relevance for cancer therapy. Cell Death Dis. 2020;11(11):1013–1020. doi: 10.1038/s41419-020-03221-2.
  • Ahmed A, Tait S. Targeting immunogenic cell death in cancer. Mol Oncol. 2020;14(12):2994–3006. doi: 10.1002/1878-0261.12851.
  • Kim B, Seo Y, Kwon JH, et al. IL-6 and IL-8, secreted by myofibroblasts in the tumor microenvironment, activate HES1 to expand the cancer stem cell population in early colorectal tumor. Mol Carcinog. 2021;60(3):188–200. doi: 10.1002/mc.23283.
  • Oh S, Kim HM, Batsukh S, et al. High-Intensity focused ultrasound induces adipogenesis via control of cilia in Adipose-Derived stem cells in subcutaneous adipose tissue. Int J Mol Sci. 2022;23(16):8866. doi: 10.3390/ijms23168866.